News & Alerts
-
Dec- 2023 -19 December
GSK’s Cancer Drug Combination Achieves Primary Goal in Late-Stage Trial for Endometrial Cancer
GlaxoSmithKline (GSK) announced on Monday that the combination of its cancer drugs Zejula and Jemperli, utilized as a maintenance therapy…
Read More » -
19 December
Weight-Loss Drug Excitement Overshadows Market Realities in 2023
In 2023, the enthusiasm surrounding weight-loss drugs, particularly Novo Nordisk’s Wegovy (also known as Ozempic) and Eli Lilly’s Zepbound, has…
Read More » -
19 December
IndiaMART Removes Unauthorized Listings of Novo Nordisk’s Wegovy Following Talks
IndiaMART, a prominent Indian online marketplace, has taken steps to remove unauthorized listings of Novo Nordisk’s blockbuster weight-loss drug Wegovy,…
Read More » -
19 December
Jordan Foils Armed Plot by Infiltrators from Syria Linked to Pro-Iranian Militias
The Jordanian army successfully thwarted a major cross-border operation on Monday, revealing a plot orchestrated by dozens of infiltrators from…
Read More » -
18 December
RNAimmune, Partner of Innoforce, Receives FDA IND Clearance for Groundbreaking RSV mRNA Vaccine
RNAimmune, Inc., a strategic partner of Innoforce Pharmaceuticals, has achieved a major milestone with the U.S. Food and Drug Administration…
Read More » -
18 December
FDA Clears NRX-101: Investigational Drug for Complicated UTIs by NRx
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, has announced a significant milestone with the FDA’s clearance of its…
Read More » -
18 December
Menopause Market Report 2019-2032: Insights, Forecast, and Analysis
In a groundbreaking move, Research and Markets has released a comprehensive report titled “Menopause – Market Insights, Epidemiology and Market…
Read More » -
18 December
Merck & Co. (MRK) Under Heavy Institutional Influence – What Investors Need to Know!
In a recent analysis by Simply Wall St, it has been revealed that Merck & Co., Inc. (NYSE:MRK) is overwhelmingly…
Read More » -
15 December
10 Most Abused Drugs In Africa
Recently the African Union held a high-level session on addressing substance use and related mental health disorders among youth, women,…
Read More » -
15 December
Technavio Predicts Significant Growth in Global Sjogren’s Syndrome Therapeutics Market by 2027
The Sjogren’s Syndrome Therapeutics Market is poised for substantial growth, with Technavio projecting an estimated increase of USD 691.09 million…
Read More »